Seehra Jasbir
- SEC CIK
- 0001732369
In the past year, 1 open-market sale filing worth $113.4K and no purchases.
Current role at each company
- KROS Keros Therapeutics, Inc.CHIEF EXECUTIVE OFFICERas of Apr 6, 2026
- ELOX Eloxx Pharmaceuticals, Inc.Directoras of Jun 17, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $113.4K
- 1 filing
- Net
- −$113.4K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Seehra Jasbir as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
KROS Keros Therapeutics, Inc.
CHIEF EXECUTIVE OFFICER1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 20, 2026 (view filing) | Feb 19 | 1 day | Seehra JasbirCHIEF EXECUTIVE OFFICER | SSale | −7.01K | $16.17 | −$113.4K | −1.8%385.7K after |